70 /100
HIGH RISK
Score updated May 30, 2026

YCBD — cbdMD, Inc. Dilution Risk Tracker

Track YCBD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track YCBD — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
65
💰 Cash Runway
85
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
65%
💰 Capital Raise 73%
• Low cash runway: 4 months remaining
• Active shelf registration ($2M, 27% of market cap)
🔄 Reverse Split 70%
• 50-day avg $0.79 below $1 exchange minimum
• Only 4 months cash — financial pressure
🔁 Convertible Conversion 40%
• Significant convertible debt: 17% potential dilution
• Elevated convertible risk (60/100)
🔔 Track YCBD — Get forecast alerts →

💹 Market Data

Market Cap$8.31M
Shares Outstanding10.50M
Float10.20M
Cash$2.64M
Debt$415.1K
Short InterestN/A

🏛 Institutional Holdings

9.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track YCBD for full holder detail →

📉 Short Interest

Short Interest770.9K
Days to Cover1.6
% of Float7.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Jun 30, 2024
xbrl XBRL WARRANT Sep 30, 2022
EFFECT EFFECT Mar 04, 2026
S-1/A SHELF Feb 20, 2026
S-1 SHELF Jan 22, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track YCBD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking YCBD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for YCBD
📊 YCBD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 YCBD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.